Mitchell Capital Management CO Astrazeneca PLC Transaction History

Mitchell Capital Management CO

$549 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $44,251 - $49,535	-715 Reduced 3.95%	17,377 $1.17 Million
Q3 2023 Nov 03, 2023	SELL	$64.85 - $71.7 $7,846 - $8,675	-121 Reduced 0.66%	18,092 $1.23 Million
Q2 2023 Aug 08, 2023	BUY	$69.91 - $75.81 $59,563 - $64,590	852 Added 4.91%	18,213 $1.3 Million
Q1 2023 May 08, 2023	BUY	$63.15 - $71.6 $4,231 - $4,797	67 Added 0.39%	17,361 $1.21 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $2,222 - $2,888	41 Added 0.24%	17,294 $1.17 Million
Q3 2022 Oct 28, 2022	SELL	$53.02 - $135.75 $26,881 - $68,825	-507 Reduced 2.85%	17,253 $946,000
Q2 2022 Jul 29, 2022	BUY	$59.26 - $71.14 $11,496 - $13,801	194 Added 1.1%	17,760 $1.17 Million
Q1 2022 Apr 29, 2022	BUY	$55.72 - $67.12 $53,881 - $64,905	967 Added 5.83%	17,566 $1.17 Million
Q4 2021 Jan 28, 2022	BUY	$54.02 - $63.83 $5,131 - $6,063	95 Added 0.58%	16,599 $967,000
Q3 2021 Nov 02, 2021	BUY	$55.56 - $60.79 $14,612 - $15,987	263 Added 1.62%	16,504 $991,000
Q2 2021 Aug 10, 2021	BUY	$48.42 - $60.18 $59,847 - $74,382	1,236 Added 8.24%	16,241 $973,000
Q1 2021 Apr 29, 2021	BUY	$47.16 - $54.44 $130,538 - $150,689	2,768 Added 22.62%	15,005 $746,000
Q4 2020 Feb 08, 2021	SELL	$48.52 - $58.02 $488,499 - $584,145	-10,068 Reduced 45.14%	12,237 $612,000
Q3 2020 Nov 10, 2020	SELL	$53.07 - $61.1 $11,993 - $13,808	-226 Reduced 1.0%	22,305 $1.22 Million
Q2 2020 Jul 29, 2020	SELL	$43.1 - $55.31 $95,337 - $122,345	-2,212 Reduced 8.94%	22,531 $1.19 Million
Q1 2020 May 06, 2020	BUY	$37.79 - $51.33 $91,338 - $124,064	2,417 Added 10.83%	24,743 $1.11 Million
Q4 2019 Feb 07, 2020	SELL	$42.46 - $50.46 $13,587 - $16,147	-320 Reduced 1.41%	22,326 $1.11 Million
Q3 2019 Nov 07, 2019	BUY	$40.12 - $45.47 $126,498 - $143,366	3,153 Added 16.18%	22,646 $1.01 Million
Q2 2019 Jul 24, 2019	BUY	$37.28 - $41.68 $11,929 - $13,337	320 Added 1.67%	19,493 $805,000
Q1 2019 May 02, 2019	SELL	$35.49 - $43.02 $41,807 - $50,677	-1,178 Reduced 5.79%	19,173 $775,000
Q4 2018 Feb 08, 2019	SELL	$36.86 - $41.49 $884 - $995	-24 Reduced 0.12%	20,351 $773,000
Q3 2018 Nov 08, 2018	BUY	$34.76 - $39.72 $116,550 - $133,181	3,353 Added 19.7%	20,375 $806,000
Q2 2018 Aug 10, 2018	BUY	$34.55 - $37.05 $135,401 - $145,198	3,919 Added 29.91%	17,022 $598,000
Q1 2018 May 04, 2018	BUY	$32.97 - $36.63 $168,245 - $186,922	5,103 Added 63.79%	13,103 $458,000
Q4 2017 Feb 13, 2018	BUY	$32.09 - $34.78 $57,120 - $61,908	1,780 Added 28.62%	8,000 $278,000
Q3 2017 Oct 31, 2017	BUY	$28.96 - $34.0 $180,131 - $211,480	6,220	6,220 $211,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Capital Management CO with notifications on news.

Account